Mirtimash 30 mg 30 tablets
Composition
Each tablet contains
• Mirtazapine — 30 mg
Pharmacological properties
Mirtazapine is a tetracyclic antidepressant with the following effects:
4. Antidepressant action
• Blocks α2-adrenergic receptors and enhances the transmission of serotonin and norepinephrine
• Increases the activity of 5-HT1 receptors and reduces the stimulation of 5-HT2 and 5-HT3
5. Anxiolytic and sedative action
• Has a pronounced sedative effect, especially in the initial stages of therapy
• Reduces anxiety, improves sleep
6. Appetite and body weight
• May cause increased appetite and weight gain
Indications for use
• Major depressive disorder (MDD)
• Anxiety disorders
• Insomnia due to depression
• PTSD, generalized anxiety disorder (as prescribed by a doctor)
Method of administration and dosage
• Recommended initial dose: 15–30 mg once a day, preferably in the evening before bedtime
• Maintenance dose: 15–45 mg/day, depending on the clinical response
• The tablet should be taken whole with water, regardless of food intake
• The effect may appear after 1–2 weeks, the full therapeutic effect – after 3–4 weeks
• Do not stop taking the drug abruptly – a gradual reduction in the dose is necessary.